Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non–skull base meningiomas
Department of Neurosurgery, Toronto Western Hospital, University Health Network, Toronto;
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton; and
Search for other papers by Alireza Mansouri in
Current site
Google Scholar
PubMed
Department of Neurosurgery, Toronto Western Hospital, University Health Network, Toronto;
Search for other papers by George Klironomos in
Current site
Google Scholar
PubMed
Department of Neurosurgery, Toronto Western Hospital, University Health Network, Toronto;
Search for other papers by Shervin Taslimi in
Current site
Google Scholar
PubMed
Search for other papers by Alex Kilian in
Current site
Google Scholar
PubMed
Department of Neurosurgery, Toronto Western Hospital, University Health Network, Toronto;
Search for other papers by Fred Gentili in
Current site
Google Scholar
PubMed
Department of Neurosurgery, Toronto Western Hospital, University Health Network, Toronto;
Search for other papers by Osaama H. Khan in
Current site
Google Scholar
PubMed
Search for other papers by Kenneth Aldape in
Current site
Google Scholar
PubMed
Department of Neurosurgery, Toronto Western Hospital, University Health Network, Toronto;
Search for other papers by Gelareh Zadeh in
Current site
Google Scholar
PubMed
OBJECTIVE
The objective of this study was to identify the natural history and clinical predictors of postoperative recurrence of skull base and non–skull base meningiomas.
METHODS
The authors performed a retrospective hospital-based study of all patients with meningioma referred to their institution from September 1993 to January 2014. The cohort constituted both patients with a first-time presentation and those with evidence of recurrence. Kaplan-Meier curves were constructed for analysis of recurrence and differences were assessed using the log-rank test. Cox proportional hazard regression was used to identify potential predictors of recurrence.
RESULTS
Overall, 398 intracranial meningiomas were reviewed, including 269 (68%) non–skull base and 129 (32%) skull base meningiomas (median follow-up 30.2 months, interquartile range [IQR] 8.5–76 months). The 10-year recurrence-free survival rates for patients with gross-total resection (GTR) and subtotal resection (STR) were 90% and 43%, respectively. Skull base tumors were associated with a lower proliferation index (0.041 vs 0.062, p = 0.001), higher likelihood of WHO Grade I (85.3% vs 69.1%, p = 0.003), and younger patient age (55.2 vs 58.3 years, p = 0.01). Meningiomas in all locations demonstrated an average recurrence rate of 30% at 100 months of follow-up. Subsequently, the recurrence of skull base meningiomas plateaued whereas non–skull base lesions had an 80% recurrence rate at 230 months follow-up (p = 0.02). On univariate analysis, a prior history of recurrence (p < 0.001), initial WHO grade following resection (p < 0.001), and the inability to obtain GTR (p < 0.001) were predictors of future recurrence. On multivariate analysis a prior history of recurrence (p = 0.02) and an STR (p < 0.01) were independent predictors of a recurrence. Assessing only patients with primary presentations, STR and WHO Grades II and III were independent predictors of recurrence (p < 0.001 for both).
CONCLUSIONS
Patients with skull base meningiomas present at a younger age and have less aggressive lesions overall. Extent of resection is a key predictor of recurrence and long-term follow-up of meningiomas is necessary, especially for non–skull base tumors. In skull base meningiomas, recurrence risk plateaus approximately 100 months after surgery, suggesting that for this specific cohort, follow-up after 100 months can be less frequent.
ABBREVIATIONS
© Copyright 1944-2025 American Association of Neurological Surgeons. All rights reserved, including those for text and data mining, AI training, and similar technologies.